Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SATO Vicinity is an Australian RFID technology company focused on high-performance identification and traceability solutions, particularly for healthcare, blood and pathology, and related regulated environments. Established in 2013 by SATO Holdings Corporation from the business acquired from Magellan Technology, the company commercializes ISO 18000-3 Mode 2 PJM RFID products and solutions. Its offerings support medical device tracking, asset and inventory management, blood product tracking, and workflow accuracy in settings where read reliability is critical. SATO Vicinity operates as part of the broader SATO Group and appears to be a commercial-stage operating business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SATO Vicinity.